Viralogic Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Viralogic Therapeutics, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include KELONIA and KELONIA THERAPEUTICS. The owner is based in Boston, MA.
3rd Floor
34 Farnsworth St.
Boston, MA 02210
Showing of trademarks Trademarks
Trademark Classifications
Viralogic Therapeutics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Viralogic Therapeutics, Inc. have?
Viralogic Therapeutics, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 abandoned.
What trademark classes does Viralogic Therapeutics, Inc. file in?
Viralogic Therapeutics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Viralogic Therapeutics, Inc.'s most well-known trademarks?
Viralogic Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as KELONIA and KELONIA THERAPEUTICS. These are among 7 currently registered trademarks in the portfolio.
What is Viralogic Therapeutics, Inc.'s trademark registration success rate?
Viralogic Therapeutics, Inc. has a 78% trademark registration rate, with 7 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.